Showing results (41-50 of 734) with videos related to
Sort By:
Pageof 74
Current Opinion in Molecular Therapeutics|June 16, 2004
Antibody therapy for non-Hodgkin's lymphomaStephen M AnsellClinical and Experimental Rheumatology|September 1, 1994
How should pediatric rheumatology be delivered?B M AnsellHematology. American Society of Hematology. Education Program|December 10, 2017
Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyondStephen M AnsellExpert Opinion on Investigational Drugs|December 3, 2010
Brentuximab vedotin: delivering an antimitotic drug to activated lymphoma cellsStephen M AnsellAmerican Journal of Hematology|June 24, 2014
Hodgkin lymphoma: 2014 update on diagnosis, risk-stratification, and managementStephen M AnsellScience & Justice : Journal of the Forensic Science Society|November 30, 2000
Using Raman spectroscopy to solve crime: inks, questioned documents and fraudM Claybourn, M AnsellCancer Cell|November 5, 2021
PHOENIX rises: Genomic-based therapies for diffuse large B cell lymphomaPatrizia Mondello, Stephen M AnsellBest Practice & Research. Clinical Haematology|November 10, 2016
Bone marrow microenvironment in Waldenstrom's MacroglobulinemiaShahrzad Jalali, Stephen M AnsellBlood and Lymphatic Cancer : Targets and Therapy|July 31, 2019
Waldenström macroglobulinemia: biology, genetics, and therapyJonas Paludo, Stephen M AnsellFrontiers in Cell and Developmental Biology|April 24, 2023
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignanciesVaishali Bhardwaj, Stephen M AnsellPageof 74